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Osteogenesis imperfecta (OI) is a disease of type I collagen whose hallmark is extreme 
bone fragility manifested by numerous fractures throughout life. OI is usually caused by 
decreased amounts of type I collagen and/or the production of abnormal collagen, 
leading to biomechanically impaired extracellular matrix. Osteoblasts are cells that build 
the matrix constituents of bone by secreting collagen, which, along with hydroxyapatite 
crystals, forms the composite structure of bone.  It is unclear how osteoblasts respond 
to a structurally compromised matrix at a cellular level. This project is a pilot study to 
explore how osteoblasts from the osteogenesis imperfecta mouse (oim) model differ 
from wildtype osteoblasts, and how these differences contribute to the structurally 
inferior bone matrix of oim mice. Because there is no established protocol for growing 
and mineralizing oim osteoblasts in tissue culture, the main focus of my summer 
research has been developing such a protocol. Osteoblasts were harvested from 
calvaria taken from oim and wildtype mice at three to four days of age using a trypsin-
collagenase solution. The cells were then grown in α-MEM in 12-well plates and 
encouraged to mineralize using β-glycerol phosphate and ascorbic acid. Because the 
outcome measures are protein quantification, fibroblast cultures have been used to help 
develop the protocols for measuring hydroxyproline, an amino acid unique to collagen, 
as well as western blotting of type I collagen. While the protocol for growing and 
mineralizing osteoblasts is still in development, we have finalized our harvesting and 
plating procedures, allowing to us effectively grow both wildtype and oim osteoblasts in 
culture.
 
